Abstract 1626: CDK9 inhibition enhances apoptosis of TP53 mutated AML when combined with standard chemotherapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Massachusetts General Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409625344
